Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alector Inc (ALEC)
NASDAQ:ALEC
Alector (ALEC) Stock Price & Analysis
391 Followers
ALEC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.66 - $9.07
Previous Close$5.44
Volume544.59K
Average Volume (3M)595.49K
Market Cap
$524.33M
Enterprise Value$14.39M
Total Cash (Recent Filing)$548.86M
Total Debt (Recent Filing)$38.92M
Price to Earnings (P/E)-3.9
Beta0.90
Next Earnings
Aug 01, 2024EPS Estimate
-$0.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.39
Shares Outstanding96,384,562
10 Day Avg. Volume423,366
30 Day Avg. Volume595,487
Standard Deviation0.19
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)3.91
Price to Sales (P/S)34.52
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.15
Enterprise Value/Gross Profit0.15
Enterprise Value/Ebitda-0.11
Forecast
1Y Price Target
$16.20Price Target Upside197.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Alector News
PremiumCompany Announcements
Alector Inc Announces Board Retirement and New Members
Bulls Say, Bears Say
Bulls Say
Clinical Development ProgressKey clinical catalysts for ALEC's Alzheimer's and dementia treatments are confirmed to be on schedule.
Financial StabilityAlector's financial position is strong with sufficient cash to support operations through key data readouts.
Leadership And InnovationNew Chief Business Officer and Board members announced, indicating a strengthening of the leadership team.
Bears Say
Analyst RecommendationAnalyst has lowered the price target to $35 from $41, reflecting revised operational expense assumptions in light of development programs.
Clinical Trial RiskGiven the ongoing clinical programs which are still relatively far from derisking data, the analyst reiterates a Neutral position.
Drug Development RiskAnalysts have assigned only a 25% probability of success for AL002, indicating a high risk for investment.
---
Ownership Overview
35.81% Insiders
27.08% Mutual Funds
32.77% Other Institutional Investors
4.34% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ALEC FAQ
What was Alector Inc’s price range in the past 12 months?
Alector Inc lowest stock price was $3.66 and its highest was $9.06 in the past 12 months.
What is Alector Inc’s market cap?
Currently, no data Available
When is Alector Inc’s upcoming earnings report date?
Alector Inc’s upcoming earnings report date is Aug 01, 2024 which is in 74 days.
How were Alector Inc’s earnings last quarter?
Alector Inc released its earnings results on May 08, 2024. The company reported -$0.38 earnings per share for the quarter, beating the consensus estimate of -$0.508 by $0.128.
Is Alector Inc overvalued?
According to Wall Street analysts Alector Inc’s price is currently Undervalued.
Does Alector Inc pay dividends?
Alector Inc does not currently pay dividends.
What is Alector Inc’s EPS estimate?
Alector Inc’s EPS estimate is -$0.51.
How many shares outstanding does Alector Inc have?
Alector Inc has 96,384,560 shares outstanding.
What happened to Alector Inc’s price movement after its last earnings report?
Alector Inc reported an EPS of -$0.38 in its last earnings report, beating expectations of -$0.508. Following the earnings report the stock price went up 0.193%.
Which hedge fund is a major shareholder of Alector Inc?
Among the largest hedge funds holding Alector Inc’s share is Deerfield Management Company, LP. It holds Alector Inc’s shares valued at 6M.
---
Alector Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.20 (197.79% Upside)
$16.20 (197.79% Upside)
Blogger Sentiment
Bullish
ALEC Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 187.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $281.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.8%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.60%
12-Months-Change
Fundamentals
Return on Equity
-66.65%
Trailing 12-Months
Asset Growth
-15.08%
Trailing 12-Months
Company Description
Alector Inc
Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
---
ALEC Company Deck
---
ALEC Earnings Call
Q4 2024
0:00 / 0:00
---
ALEC Stock 12 Month Forecast
Average Price Target
$16.20
▲(197.79% Upside)
Technical Analysis
Best Analysts Covering ALEC
1 Year
1 Year Success Rate
4/10 ratings generated profit
1 Year Average Return
+1.14%
assigned a buy rating 3 months ago
Copying Yaron Werber's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +1.14% per trade.
---